MedTrace Logo

Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain

NCT03630133 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-06-17

No results posted yet for this study

Summary

Objective of study is to evaluate the procedural success rate, clinical effectiveness, and heath-economic profile using the Intercept Intraosseous Nerve Ablation System in adult subjects with chronic low back pain in the post-market setting

Conditions

  • Chronic Low Back Pain

Interventions

DEVICE

Intracept System Ablation

Radiofrequency ablation using Intracept System

Sponsors & Collaborators

  • Relievant Medsystems, Inc.

    lead INDUSTRY

Principal Investigators

  • Kevin Macadaeg, MD · Indiana Spine Group

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-08
Primary Completion
2020-02-29
Completion
2020-02-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03630133 on ClinicalTrials.gov